These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33677869)

  • 21. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
    PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferrokinetic evaluation of erythropoiesis in patients with myelodysplastic syndromes.
    Uchida T; Kokubun K; Abe R; Kimura H; Yui T; Matsuda S; Kariyone S
    Acta Haematol; 1988; 79(2):81-3. PubMed ID: 3124477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.
    Park S; Kosmider O; Maloisel F; Drenou B; Chapuis N; Lefebvre T; Karim Z; Puy H; Alary AS; Ducamp S; Verdier F; Bouilloux C; Rousseau A; Jacob MC; Debliquis A; Charpentier A; Gyan E; Anglaret B; Leyronnas C; Corm S; Slama B; Cheze S; Laribi K; Amé S; Rose C; Lachenal F; Toma A; Pica GM; Carre M; Garban F; Mariette C; Cahn JY; Meunier M; Herault O; Fenaux P; Wagner-Ballon O; Bardet V; Dreyfus F; Fontenay M
    Haematologica; 2019 Mar; 104(3):497-504. PubMed ID: 30287621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.
    Coffey R; Jung G; Olivera JD; Karin G; Pereira RC; Nemeth E; Ganz T
    Blood; 2022 Jan; 139(3):439-451. PubMed ID: 34614145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant.
    Andolfo I; Rosato BE; Marra R; De Rosa G; Manna F; Gambale A; Iolascon A; Russo R
    Am J Hematol; 2019 Nov; 94(11):1227-1235. PubMed ID: 31400017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical and biological assessment of circulating human erythroferrone.
    Appleby S; Chew-Harris J; Troughton RW; Richards AM; Pemberton CJ
    Clin Biochem; 2020 May; 79():41-47. PubMed ID: 32032568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone.
    Diepeveen L; Roelofs R; Grebenchtchikov N; van Swelm R; Kautz L; Swinkels D
    PLoS One; 2021; 16(7):e0254851. PubMed ID: 34283879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
    Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
    J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
    Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
    J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythroferrone contributes to recovery from anemia of inflammation.
    Kautz L; Jung G; Nemeth E; Ganz T
    Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of erythropoiesis: emerging concepts and therapeutic implications.
    Tang P; Wang H
    Hematology; 2023 Dec; 28(1):2250645. PubMed ID: 37639548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ineffective erythropoiesis and its treatment.
    Cazzola M
    Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
    Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
    Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
    Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
    Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor 15 in erythroid health and disease.
    Tanno T; Noel P; Miller JL
    Curr Opin Hematol; 2010 May; 17(3):184-90. PubMed ID: 20182355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.